Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Events

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

SMILE Show and Tell (Again)

Start: Aug 23, 2012 7:30:00 AM
End: Aug 23, 2012 10:00:00 AM

[broken image] Register for 'SMILE Show and Tell'
At last year’s Show and Tell, we heard from an online virtual school, a platform to democratize book publishing, and a physical product to help with dementia care.
<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>